Johann De Jong

Johann de Jong is a biomedical data scientist experienced in identifying and implementing opportunities for machine learning across the pharmaceutical R&D pipeline, ranging from target discovery to clinical development, and from oncology to neurological disorders. He obtained his PhD in Computational Cancer Biology from Delft University of Technology (the Netherlands), developing machine learning models for studying gene regulation and cancer gene discovery. After several years in academia and industry, including at the Netherlands Cancer Institute, BASF, UCB Pharma and Boehringer Ingelheim, he re-joined UCB Pharma in October 2024 as a Data Science Lead in the Integrated Insights & Advanced Analytics department centered around the analysis of real-world patient data for supporting the progression of drug candidates through preclinical and clinical development.